Meet our paw-some veterinarians by joining us in this upcoming webinar on Canine Lymphoma.

This session will provide an overview of the many different presentations of canine lymphoma. Options for treatment will be discussed with a focus on novel canine-specific medications. Lastly, findings from clinical trials on alternatives to chemotherapy will be presented. 

Learning objectives 

Describe the mechanism of action for Tanovea® and Laverdia®-CA1. 

List possible adverse reactions to Tanovea® and Laverdia®-CA1. 

Describe the efficacy of Tanovea® and Laverdia®-CA1. 

List possible side effects of doxycycline in dogs with lymphoma. 

Presented by: 

Kelly R. Hume, DVM, DACVIM (Oncology) 

Associate Professor, Department of Clinical Sciences 

Adjunct Associate Professor, Department of Biomedical Sciences, Cornell University College of Veterinary Medicine